Pacific Biosciences Of California Profit Margin 2009-2020 | PACB
Current and historical gross margin, operating margin and net profit margin for Pacific Biosciences Of California (PACB) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Pacific Biosciences Of California net profit margin as of March 31, 2020 is -61.85%.
|Pacific Biosciences Of California Annual Profit Margins
|Pacific Biosciences Of California Quarterly Profit Margins
||Medical Instruments Manufacturing
Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.